It's Relevant: Local News, Sports and Deals
Stamford Edition
Change to: Greenwich | Norwalk | Westport

 
< PREV STORY
Slide The City Comes to Stamford
NEXT STORY >
Flood Risk Estimates May Be Low

IT'S RELEVANT ORIGINAL

FDA Approves New Drug Dubbed the Female Viagara

Flibanserin headed to market this October

Issue Playing Video? Please Click to Report
By:
Stamford, CT | Added on August 19, 2015 At 09:19 AM

Women who have lost their sex drive will have a little pink pill to help them come October. On Tuesday, the U.S. Food and Drug Administration approved Flibanserin, which will be sold as Addyi, for the treatment of sexual dysfunction in premenopausal women. This is the first FDA approved treatment for sexual desire in men or women. Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research said in a statement announcing the approval, "Today's approval provides women distressed by their low sexual desire with an approved treatment option." 


Share Your Thoughts

More Health/Fitness Stories

 

 

The Videos

Video Archive
Submit a News Tip
Submit a Photo

General

About Us
Contact Us
Advertise with Us
Privacy Statement
Terms and Conditions
Sitemap


divider


Ā© 2010-2013, Its Relevant, LLC

It's RelevantĀ® graphics, logos, scripts, terms of use, instructions, designs and other service names are the trademarks and copyright of It's Relevant, LLC.

Email: support@itsrelevant.com or Call: 855-487-7353